JENNIFER SADECK: Open Payments
NPI 1033595210 · DARTMOUTH, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,416 in 58 payments from 17 companies in 2025. Trend: 2023 $2,987 · 2024 $1,215 · 2025 $1,416
Food & beverage: $1,416
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 10 | $333 |
| Novo Nordisk Inc | 12 | $332 |
| Alnylam Pharmaceuticals Inc. | 4 | $100 |
| Amgen Inc. | 5 | $88 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $78 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $68 |
| Merck Sharp & Dohme LLC | 3 | $65 |
| BridgeBio Pharma, Inc. | 2 | $59 |
| PFIZER INC. | 2 | $51 |
| AstraZeneca Pharmaceuticals LP | 3 | $48 |
Products named: Wegovy, COBENFY, ELIQUIS, CAMZYOS, JARDIANCE, ONPATTRO, REPATHA, Kerendia.
Industry payments across MA — which companies pay providers there.
